Can a single PSA value distinguish cancer from benign causes?

PSA is a prostate-derived marker, but it is not a cancer-specific marker. In a 77-year-old man, an elevated result should be interpreted in clinical context rather than as a diagnosis of prostate cancer.

Clinical evidence

• Benign prostatic enlargement raises PSA as prostate volume and secretory epithelial-cell mass increase.
• Prostatitis or febrile urinary infection can cause substantial, transient PSA elevations—occasionally >100 ng/mL—with decline or normalization taking weeks to months after resolution.
• Acute urinary retention can also produce marked elevation. In one BPH-associated retention cohort, mean PSA fell from 24.6 to 9.4 ng/mL within 48 hours after bladder decompression; another study found an approximately twofold increase that may persist up to 2 weeks.
• Prostate cancer can raise PSA, but PSA expression is heterogeneous across tumors; an elevated PSA neither proves cancer nor excludes it.

Why one value cannot identify the cause

• At a total PSA threshold of ≥4 ng/mL, pooled sensitivity for biopsy-detected cancer was 93%, but specificity only 20%. Thus, many men without cancer have PSA values above this threshold.
• PSA may also rise transiently after ejaculation, urinary-tract/prostate instrumentation, and urinary infection, further undermining interpretation of an isolated result.

Mechanistic explanation

• PSA is produced mainly by prostatic luminal secretory cells. Normally, epithelial, basal-cell, stromal, and vascular barriers limit PSA’s entry into blood. Benign enlargement increases PSA-producing tissue, while inflammation, retention-associated disturbance, and malignant architectural disruption can increase leakage into circulation.

Clinical implications

• A newly elevated PSA is generally repeated before secondary biomarkers, MRI, or biopsy. For PSA 3–10 ng/mL with normal examination and no infection, repeat testing after about 4 weeks under standardized conditions is recommended.

Bottom line

• The claim is well supported: PSA is prostate-specific but not cancer-specific, and a single elevated value cannot distinguish benign enlargement, prostatitis/infection, retention, transient influences, and prostate cancer.